Testagen

Also known as: Prostate Peptide Bioregulator

A tetrapeptide bioregulator for prostate and male reproductive health.

Overview

Testagen is a synthetic tetrapeptide from the Khavinson bioregulator family designed to support prostate and male reproductive function through gene regulatory effects.

Mechanism of Action

Gene regulatory effects on prostate tissue. May support healthy prostate cell function and hormone balance. Proposed epigenetic modulation.

Pharmacokinetics

Small peptide allows oral administration. Tissue-specific effects on prostate.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Oral

Dose

10-20 mg

Frequency

1-2x daily

Duration

10-30 days

2-3 courses per year

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Male reproductive health

Synergy: Prostate support plus testicular function

Research Areas

Prostate HealthMale Reproductive FunctionBPHMale Aging

Key Research Findings

  • 1Improved prostate function markers in elderly men
  • 2Gene expression modulation in prostate tissue
  • 3Potential for BPH symptom management
  • 4Part of comprehensive male health protocols in Russia

Side Effects & Contraindications

Reported Side Effects

  • Generally well-tolerated

Contraindications

  • Prostate cancer
  • Elevated PSA (investigate first)

Safety Considerations

Generally well-tolerated. Limited Western clinical data. Avoid in prostate cancer.

Storage Requirements

Store at room temperature

Scientific References

Quick Reference

Sequence
Lys-Glu-Asp-Trp
Molecular Weight
562.6 g/mol
Half-Life
Short
Bioavailability
Oral/sublingual
Research Stage
clinical phase 2
Administration
Oral or sublingual